Patents by Inventor Cathy Chu

Cathy Chu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250099425
    Abstract: A pharmaceutical composition comprising Compound I: Methods of treating cystic fibrosis comprising administering one or more of such pharmaceutical compositions to a patient.
    Type: Application
    Filed: April 23, 2024
    Publication date: March 27, 2025
    Applicant: Vertex Pharmaceuticals Incorporated
    Inventors: Cathy CHU, Varsha DHAMANKAR, Eleni DOKOU, Eric L. HASELTINE, Samuel MOSKOWITZ, Sarah ROBERTSON, David WALTZ, Weichao George CHEN
  • Publication number: 20240285596
    Abstract: Provided is a solid dispersion of (2R,3S,4S,5R)-4-[[3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl) tetrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamide (Compound 1), defined as described herein, or a pharmaceutically acceptable salt thereof and a tablet containing the solid dispersion for treating pain. Also disclosed herein is Compound 1 or a pharmaceutically acceptable salt thereof for use in a method of treating pain.
    Type: Application
    Filed: June 3, 2022
    Publication date: August 29, 2024
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Radhika KARKARE, Cathy CHU, Brenda CIRINCIONE, Darin J. CORRELL, Philip Kaj Harder DELFF, Kirk Raymond DINEHART, Paloma BENITO GALLO, Tanya Louise HAY, Licong JIANG, James B. JONES, Katie L. MCCARTY, Catherine P. METZLER, Jonathan M. MILLER, Mark C. PETERSON, Rahul ROOPWANI, John F. STAROPOLI
  • Publication number: 20220257564
    Abstract: A pharmaceutical composition comprising Compound I: Methods of treating cystic fibrosis comprising administering one or more of such pharmaceutical compositions to a patient.
    Type: Application
    Filed: September 15, 2021
    Publication date: August 18, 2022
    Applicant: Vertex Pharmaceuticals Incorporated
    Inventors: Cathy Chu, Varsha Dhamankar, Eleni Dokou, Eric L. Haseltine, Samuel Moskowitz, Sarah Robertson, David Waltz, Weichao George Chen
  • Patent number: 11179367
    Abstract: A pharmaceutical composition comprising Compound I: Methods of treating cystic fibrosis comprising administering one or more of such pharmaceutical compositions to a patient.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: November 23, 2021
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Cathy Chu, Varsha Dhamankar, Eleni Dokou, Eric L. Haseltine, Samuel Moskowitz, Sarah Robertson, David Waltz, Weichao George Chen
  • Publication number: 20210069174
    Abstract: Compositions comprising Compound I of the formula (I) and methods of treating cystic fibrosis comprising administering Compound I. Compositions comprising a pharmaceutically acceptable salt of Compound I and methods of treating cystic fibrosis comprising administering a pharmaceutically acceptable salt of Compound I.
    Type: Application
    Filed: June 29, 2018
    Publication date: March 11, 2021
    Inventors: Cathy Chu, Eleni Dokou, Eric L. Haseltine, Samuel Moskowitz, Kirk A. Overhoff, Sarah Robertson, David Waltz
  • Publication number: 20190240197
    Abstract: A pharmaceutical composition comprising Compound I: Methods of treating cystic fibrosis comprising administering one or more of such pharmaceutical compositions to a patient.
    Type: Application
    Filed: February 4, 2019
    Publication date: August 8, 2019
    Applicant: Vertex Pharmaceuticals Incorporated
    Inventors: Cathy Chu, Varsha Dhamankar, Eleni Dokou, Eric L. Haseltine, Samuel Moskowitz, Sarah Robertson, David Waltz, Weichao George Chen